
Meningioma Study: Depo-Provera and Its Observed Mutation Shift
“This shift in mutational landscape indicates the vulnerability of certain meningeal cells and mutations to hormone-induced tumorigenesis,” states M. Peyre, Neurosurgeon. Greg Vigna, MD, JD, national pharmaceutical injury attorney, states,…